BE572349A - - Google Patents
Info
- Publication number
- BE572349A BE572349A BE572349DA BE572349A BE 572349 A BE572349 A BE 572349A BE 572349D A BE572349D A BE 572349DA BE 572349 A BE572349 A BE 572349A
- Authority
- BE
- Belgium
- Prior art keywords
- polycarbonates
- active materials
- active
- substances
- materials
- Prior art date
Links
- 229920000515 polycarbonate Polymers 0.000 claims description 15
- 239000004417 polycarbonate Substances 0.000 claims description 15
- 239000011149 active material Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 230000001681 protective effect Effects 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 229920002261 Corn starch Polymers 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 239000008120 corn starch Substances 0.000 description 6
- 239000008298 dragée Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 239000000470 constituent Substances 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- SAZUGELZHZOXHB-UHFFFAOYSA-N acecarbromal Chemical compound CCC(Br)(CC)C(=O)NC(=O)NC(C)=O SAZUGELZHZOXHB-UHFFFAOYSA-N 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- VCCBEIPGXKNHFW-UHFFFAOYSA-N biphenyl-4,4'-diol Chemical group C1=CC(O)=CC=C1C1=CC=C(O)C=C1 VCCBEIPGXKNHFW-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE572349A true BE572349A (enrdf_load_stackoverflow) |
Family
ID=190181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE572349D BE572349A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE572349A (enrdf_load_stackoverflow) |
-
0
- BE BE572349D patent/BE572349A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0233853B1 (fr) | Couples effervescents, compositions effervescentes d'antagonistes H2 de l'histamine les contenant et leur préparation | |
| EP0078785B1 (fr) | Sels d'acide valproîque, leur préparation et leur utilisation | |
| EP0608207B1 (fr) | Compositions pharmaceutiques contenant des nanocapsules | |
| EP1039913B1 (fr) | Comprime de progesterone et son procede de preparation | |
| FR2550092A1 (fr) | Preparation medicamenteuse solide a deux phases et son procede d'obtention | |
| FR2670488A1 (fr) | Composition pharmaceutique contenant une forme physique particuliere d'un amide heterocyclique et son procede de preparation. | |
| FR2542998A1 (fr) | Nouvelle forme transdermale du dinitrate d'isosorbide | |
| EP0377370A1 (fr) | Procédé d'encapsulation de particules au moyen d'un copolymère silicone thermoplastique et particules enrobées | |
| CH617068A5 (enrdf_load_stackoverflow) | ||
| FR2571617A1 (fr) | Procede pour la microencapsulation par separation de phases de substances medicamenteuses hydrosolubles | |
| BE1000496A7 (fr) | Procede pour la production de preparations pharmaceutiques ayant une haute capacite de fixation de l'acide gastrique, exercant un effet retard et ayant une biodisponibilite accrue. | |
| EP0601911B1 (fr) | Acylaminoacides obtenus par l'acylation d'hydrolysats de protéines et compositions anti-microbiennes, antiparasitaires ou cosmétiques en contenant | |
| CA2287485A1 (fr) | Nouveau procede d'obtention de microspheres et les produits ainsi realises | |
| BE572349A (enrdf_load_stackoverflow) | ||
| BE1001687A5 (fr) | Composition a base de polyesters pour la liberation controlee de substances medicamenteuses. | |
| BE898430A (fr) | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation. | |
| EP0092287B1 (fr) | Sels d'acétylcystéine, leur préparation et leur utilisation | |
| FR2620450A1 (fr) | Nouveaux sels de composes organogermaniques et medicaments les contenant | |
| FR2571619A1 (fr) | Produit pharmaceutique depourvu de glucocorticoides pour le traitement local du psoriasis | |
| EP0149864A1 (fr) | Compositions molluscicides et procédés pour leur obtention et leur utilisation | |
| CA1140155A (fr) | PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU 1.alpha.,25-DIHYDROXY CHOLECALCIFEROL | |
| FR2702375A1 (fr) | Microcapsules à libération progressive, leur procédé de préparation et compositions pharmaceutiques ou vétérinaires les contenant. | |
| CH665558A5 (en) | Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage | |
| EP0487431B1 (fr) | Compositions pharmaceutiques à action laxative et leur procédé de préparation | |
| BE892421A (fr) | Compositions pharmaceutiques contenant de l'argentico-sulfadiazine comme substance active et procedes de preparation de ces compositions |